COMPANY PROFILE

PeakData

Explore full profile

AI-driven, actionable insights to the world’s leading pharmaceutical companies

Zug, SwitzerlandFounded 2017Biotech & Life Sciences

Valuation $50–100M Last recorded · 2022

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About PeakData

PeakData is a technology startup specializing in artificial intelligence (AI) solutions tailored for the healthcare sector, particularly the pharmaceutical industry. The company leverages big data to enhance the effectiveness of pharmaceutical sales teams and provides influence mapping for Key Account Management (KAM). Operating in a global market, PeakData serves some of the largest pharmaceutical brands across 14 countries, impacting over 1 million physicians. The business model revolves around offering AI-driven analytics and data solutions that help pharmaceutical companies optimize their commercial strategies. Revenue is generated through subscription-based services and customized AI solutions for clients. PeakData ensures full compliance with GDPR, making it a trusted partner for data-related challenges in the European market.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Zug, Switzerland
Employees: 48
Open positions: None listed
Dealroom signal: 62.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Techbio, Techbio Drug Discovery, Digital Pharma, DT and LS, science-based, Swiss DT TechBio
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Aug 2022	$12M	$49M	Heal capital · Octopus Ventures · AlbionVC	↗
SERIES A✓Equity / VC	Jun 2022	$3.1M	$12M	Octopus Ventures · Hemex	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

PeakData website traffic

Latest recorded traffic for PeakData is 8K monthly website visits, down 52.9% over the last three months. PeakData's team declined 17.2% over the past year.

Latest monthly visits8K 3-month web change-52.9% 1-year team growth-17.2%

Monthly website visitsJan 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
STSTALICLATranslating precision medicine for Autism Spectrum Disorder	Geneva, Switzerland	Operational	23	$57M	$68M
GEGenomSysSolutions and Systems for Efficient Genomic Information Processing	Lausanne, Switzerland	Operational
EPEpiternaDeveloping affordable products that can safely slow the ageing process to prevent age-related disease, delay functional decline, and extend life	Epalinges, Switzerland	Operational
NBNew BiologixEngineered cell line technology that produces safe and effective AAV drugs for gene therapy, making treatments more affordable and accessible	Epalinges, Switzerland	Operational
CRCradleAI-powered protein design and engineering platform.	Amsterdam, Netherlands	Operational
LILimulaProposes a closed and automated cell therapy manufacturing platform that operates at the point of care	Epalinges, Switzerland	Operational
SCScailyteDeveloping artificial intelligence technology for the discovery of complex disease patterns from single-cell data	Basel, Switzerland	Operational
IBInterAx BiotechDelivering High-Quality Drug Candidates for GPCR Targets	Villigen, Switzerland	Operational